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ABSTRACT: Low-density lipoprotein (LDL) has recently been shown to
be oxidized by iron within the lysosomes of macrophages, and this is a novel
potential mechanism for LDL oxidation in atherosclerosis. Our aim was to
characterize the chemical and physical changes induced in LDL by iron at
lysosomal pH and to investigate the eﬀects of iron chelators and α-
tocopherol on this process. LDL was oxidized by iron at pH 4.5 and 37 °C
and its oxidation monitored by spectrophotometry and high-performance
liquid chromatography. LDL was oxidized eﬀectively by FeSO4 (5−50 μM)
and became highly aggregated at pH 4.5, but not at pH 7.4. The level of
cholesteryl esters decreased, and after a pronounced lag, the level of 7-
ketocholesterol increased greatly. The total level of hydroperoxides
(measured by the triiodide assay) increased up to 24 h and then decreased
only slowly. The lipid composition after 12 h at pH 4.5 and 37 °C was
similar to that of LDL oxidized by copper at pH 7.4 and 4 °C, i.e., rich in hydroperoxides but low in oxysterols. Previously
oxidized LDL aggregated rapidly and spontaneously at pH 4.5, but not at pH 7.4. Ferrous iron was much more eﬀective than
ferric iron at oxidizing LDL when added after the oxidation was already underway. The iron chelators diethylenetriaminepenta-
acetic acid and, to a lesser extent, desferrioxamine inhibited LDL oxidation when added during its initial stages but were unable to
prevent aggregation of LDL after it had been partially oxidized. Surprisingly, desferrioxamine increased the rate of LDL
modiﬁcation when added late in the oxidation process. α-Tocopherol enrichment of LDL initially increased the rate of oxidation
of LDL but decreased it later. The presence of oxidized and highly aggregated lipid within lysosomes has the potential to perturb
the function of these organelles and to promote atherosclerosis.
The accumulation and oxidation of low-density lipoprotein(LDL) in the arterial intima might play an important role
in atherosclerosis.1 There has been an enormous amount of
work on the mechanisms by which LDL might be oxidized, but
no consensus has emerged. Possible mechanisms involve iron,
copper, caeruloplasmin, lipoxygenase, superoxide, peroxynitrite,
and myeloperoxidase.2
There is evidence that LDL can be modiﬁed by nonoxidative
mechanisms in the arterial wall so that it is endocytosed faster
by macrophages. These include modiﬁcation by sphingomye-
linase,3 secretory phospholipase A2,
4 or cathepsin D.5 We have
proposed that nonoxidatively modiﬁed LDL might be taken up
by macrophages in atherosclerotic lesions and oxidized within
lysosomes.6 Macrophages in culture were capable of taking up
acetylated or aggregated LDL and oxidizing it in lysosomes.6
Lysosomes are a source of redox-active iron,7 and iron is
present at elevated levels in atherosclerotic lesions.7 Lysosomal
LDL oxidation may explain why oxidized LDL is present within
lesions despite the apparently strong antioxidant protection
within the arterial intima.8 Oxidized LDL formed within
lysosomes might aﬀect cell function or be released from cells
into the interstitial ﬂuid, both with potentially atherogenic
consequences.
Oxidation of LDL by copper at pH 7.4 has been extensively
characterized,9 whereas little is known about the chemical
composition of LDL oxidized by iron under the acidic
conditions present in lysosomes (pH ∼4.5). We report here
the chemical changes in LDL oxidized by iron at lysosomal pH
and the surprising eﬀects of ferrous and ferric iron, iron
chelators, and α-tocopherol.
■ MATERIALS AND METHODS
LDL Isolation. LDL (d = 1.019−1.063 g/mL) was isolated
by sequential ultracentrifugation of pooled plasma from four
healthy adult volunteers.10
Measurement of Conjugated Dienes. Conjugated diene
formation was monitored at 234 nm.11 LDL (50 μg of protein/
mL) was oxidized by freshly dissolved FeSO4 (5 μM) or FeCl3
(5 μM) at 37 °C in washed Chelex-100-treated 150 mM NaCl/
10 mM sodium acetate buﬀer (pH 4.5) or 150 mM NaCl/10
mM 3-(N-morpholino)propanesulfonic acid (MOPS) buﬀer
(pH 7.4), in capped quartz cuvettes, in an automatic six-
position (Lambda 2) or eight-position (Lambda Bio 40)
spectrophotometer (Perkin-Elmer). The FeSO4 or FeCl3 stock
solutions for the experiments at pH 4.5 were dissolved in buﬀer
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at pH 4.5, rather than in water, to prevent the rapid oxidation of
ferrous ion that occurs at higher pH values.12 The change in
attenuance at 234 nm was measured every minute at 37 °C,
against reference cuvettes lacking LDL. The attenuance at time
zero was subtracted from all values, except where stated.
Measurement of LDL Aggregation. LDL aggregation
was monitored by continuously measuring light scattering13 at
680 nm and 37 °C in the spectrophotometers mentioned
above.
LDL Oxidation for Compositional Analysis. LDL (250
μL at a concentration of 2 mg of protein/mL) was oxidized
with freshly dissolved FeSO4 (50 μM) at 37 °C in NaCl/
sodium acetate buﬀer (pH 4.5). At various times over 48 h, the
oxidation was stopped by addition of butylated hydroxytoluene
(BHT, ﬁnal concentration of 80 μM, from a 2 mM stock
solution in ethanol) and EDTA (ﬁnal concentration of 4 mM).
Preparation of Lipid Hydroperoxide-Rich and Oxy-
sterol-Rich LDL. Lipid hydroperoxide-rich LDL and oxysterol-
rich LDL were produced by oxidizing LDL with CuSO4 (10
μM) at 4 and 37 °C, respectively, in 150 mM NaCl/10 mM
MOPS buﬀer (pH 7.4), followed by dialysis in the presence of
EDTA overnight to remove copper.14
Total Hydroperoxide Content. Hydroperoxides (ROOH)
were measured using a triiodide method.15
Relative Electrophoretic Mobility. The relative electro-
phoretic mobility (REM) of oxidized LDL was measured using
a Paragon Lipogel electrophoresis system (Beckman Instru-
ments), according to the manufacturer’s instructions, with 3 μL
of LDL (2 mg of protein/mL) applied to the origin and run at
100 V for 40 min. The distance that the samples migrated was
divided by the distance migrated by native LDL.
Thiobarbituric Acid Reactive Substances (TBARS).
TBARS were assessed as described previously.16
HPLC Analysis. Lipids were extracted from oxidized LDL
for HPLC analysis using methanol and hexane.17 The upper
hexane layer was dried under a stream of nitrogen and
redissolved in 200 μL of an acetonitrile/2-propanol/water
mixture (44/54/2, by volume). Lipid species were separated by
reverse phase HPLC in a Capital C18 column (250 mm × 4.6
mm, 5 μm particle size, 5 μm guard column) with a Perkin-
Elmer 200 series HPLC system. Cholesterol and cholesteryl
esters were detected at 210 nm using an acetonitrile/2-
propanol/water mobile phase (44/54/2, by volume) and a ﬂow
rate of 1.5 mL/min. 7-Ketocholesterol and cholesteryl linoleate
hydroperoxide were detected at 234 nm using an acetonitrile/2-
propanol/water mobile phase (50/48.8/1.2, by volume) and a
ﬂow rate of 1.2 mL/min. The identities of the peaks were
Figure 1. Oxidation of LDL by FeSO4 at pH 4.5 or 7.4. (A) LDL (50 μg of protein/mL) in NaCl/sodium acetate buﬀer (pH 4.5) or NaCl/MOPS
buﬀer (pH 7.4) was incubated with 5 μM FeSO4 at 37 °C in quartz cuvettes, and oxidation was monitored by measuring the change in attenuance at
234 nm against appropriate reference cuvettes. (B) LDL (50 μg of protein/mL) in NaCl/sodium acetate buﬀer (pH 4.5) was incubated with or
without 5 μM FeSO4 at 37 °C in quartz cuvettes, and aggregation was monitored by measuring light scattering at 680 nm against appropriate
reference cuvettes. Please note that the line without FeSO4 lies over the abscissal axis. (C and D) Oxysterol-rich or lipid hydroperoxide (LOOH)-
rich oxidized LDL or native LDL (all 50 μg of protein/mL) was incubated at 37 °C (in the absence of iron) in quartz cuvettes in either NaCl/
sodium acetate buﬀer (pH 4.5) (C) or NaCl/MOPS buﬀer (pH 7.4) (D). Aggregation was monitored by measuring light scattering at 680 nm
against appropriate reference cuvettes. The lines for native LDL and LOOH-rich LDL at pH 7.4 lie on top of each other. For the sake of clarity, the
attenuance at time zero was subtracted from the data in panels A and B but not in panels C and D. These data are representative examples of at least
three independent experiments.
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conﬁrmed by mass spectrometry (data not shown), and the
lipids were quantiﬁed using commercially available standards.
Enrichment of LDL with α-Tocopherol. Blood was
centrifuged at 1500g for 30 min at 4 °C in the presence of 3
mM Na2EDTA. The plasma was incubated at 37 °C for 3 h
with α-tocopherol (1 mM) dissolved in dimethyl sulfoxide (1%
of the plasma volume) or with dimethyl sulfoxide alone (1% of
the plasma volume).18 LDL was then isolated from the
plasma.10 The α-tocopherol content of the LDL was measured
by HPLC19 after extraction using methanol and hexane17 and
drying the hexane using nitrogen. The extract was redissolved
in ethanol and injected into the column described above. The
mobile phase consisted of 99% methanol and 1% water (v/v),
with a ﬂow rate of 1 mL/min and detection at 298 nm.
Statistical Analysis. The mean and the standard error of
the mean (SEM) of n independent experiments are given.
Where appropriate, results were evaluated using a paired t test
or one-way ANOVA, with a Dunnett’s post-hoc test.
■ RESULTS
Oxidation of LDL by Ferrous Iron at pH 4.5. To
compare the oxidation of LDL by iron at lysosomal pH with the
oxidation at pH 7.4, LDL (50 μg of protein/mL) was oxidized
in NaCl/sodium acetate buﬀer (pH 4.5) or NaCl/MOPS buﬀer
(pH 7.4) at 37 °C in the presence of ferrous iron (FeSO4, 5
μM). The oxidation was followed by measuring the formation
of conjugated dienes, which absorb UV radiation at 234 nm. In
agreement with previous results,6 LDL was oxidized eﬀectively
at pH 4.5 and much less so at pH 7.4 (Figure 1A). At pH 4.5,
following a lag phase, conjugated diene formation proceeded
rapidly and then more slowly. There was then a second rapid
increase in attenuance (absorbance of UV plus UV scattering)
with rapid minor ﬂuctuations, consistent with UV scattering by
aggregates, as the aggregates move in and out of the UV beam.
This was followed by a decrease in attenuance, caused by the
LDL aggregates, which were clearly visible by eye, sedimenting
below the beam of UV radiation. Inverting the cuvette gently to
Figure 2. Comparison of the oxidation of LDL by FeSO4 and FeCl3 at pH 4.5. (A) LDL (50 μg of protein/mL) in NaCl/sodium acetate buﬀer (pH
4.5) was incubated with 5 μM FeSO4 () or 5 μM FeCl3 (---) at 37 °C in quartz cuvettes. (B and C) LDL was incubated at pH 4.5 and 37 °C with
FeSO4 (B) or FeCl3 (C) at iron concentrations of 5 (), 10 (---), or 20 μM (···). (D) LDL was incubated at pH 4.5 and 37 °C with 5 μM FeSO4
(thick solid line), and additional FeSO4 (to give a ﬁnal concentration of 10 μM) was added during the rapid oxidation phase (thin solid line), during
the slow oxidation phase (---), or at the beginning of the aggregation phase (···), as indicated by the arrows. (E) LDL was incubated at pH 4.5 and 37
°C with 5 μM FeCl3 (thick solid line), and additional FeCl3 (to give a ﬁnal concentration of 10 μM) was added at the start of the reaction (thin solid
line), during the rapid oxidation phase (---), or during the slow oxidation phase (···), as indicated by the arrows. Oxidation was monitored by
measuring the change in attenuance at 234 nm against appropriate reference cuvettes. These data are representative examples of at least three
independent experiments.
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resuspend the aggregates increased the attenuance. Light
scattering was also measured by continuously measuring the
attenuance at 680 nm. Light scattering increased rapidly at
∼200 min, corresponding with the second rapid phase at 234
nm, and decreased at ∼500 min (Figure 1B). There was no
light scattering in the absence of iron, showing that LDL
aggregation and sedimentation were due to LDL oxidation
(Figure 1B).
LDL Aggregation at pH 4.5. We tested if oxidized LDL
would spontaneously aggregate at pH 4.5, regardless of whether
iron was present. LDL that had previously been oxidized with
CuSO4 to give a species rich in lipid hydroperoxides (LOOH)
or oxysterols followed by removal of the CuSO4
14 was
incubated at pH 4.5 or 7.4 and 37 °C. Both oxidized forms
of LDL aggregated rapidly at pH 4.5, whereas native LDL did
not (Figure 1C). Oxysterol-rich LDL aggregated even more
rapidly than LOOH-rich LDL, indicating that the extent to
which the LDL was oxidized aﬀected its aggregation rate. In
contrast, none of the lipoprotein species aggregated at pH 7.4
(Figure 1D).
Oxidation of LDL by Ferrous or Ferric Iron. It has been
reported that phagolysosomes in macrophages contain ferrous
iron and probably ferric iron.20 Iron will cycle between the two
forms during LDL oxidation, and it was therefore of interest to
examine the oxidation of LDL with ferrous and ferric iron. LDL
was oxidized at pH 4.5 and 37 °C in the presence initially of
ferrous iron (5 μM FeSO4) or ferric iron (5 μM FeCl3) (Figure
2A). The oxidation reaction proceeded at a faster rate with
ferrous iron than with ferric iron. The time taken to reach an
attenuance of 0.1 was 27 ± 6 min in the presence of ferrous
iron compared with 79 ± 6 min in the presence of ferric iron (p
< 0.05; paired t test; n = 9 independent experiments).
Increasing the concentration of ferrous iron to 10 or 20 μM
at the start of the oxidation caused an increase in attenuance
attained during the rapid phase (Figure 2B), whereas increasing
the concentration of ferric iron surprisingly had no eﬀect on the
oxidation kinetics (Figure 2C).
We postulated that the rapid phase of the oxidation reaction
with ferrous iron was caused predominantly by ferrous iron and
the slower phase was caused when most of the ferrous iron had
been converted to ferric iron. This theory was investigated via
addition of further iron at diﬀerent times during the oxidation
reaction and examination of the eﬀects on the kinetics of LDL
oxidation. When additional 5 μM ferrous iron was added to
LDL oxidized by FeSO4 at various time points, there was an
immediate rapid burst of oxidation (Figure 2D). In contrast,
adding additional 5 μM FeCl3 to LDL oxidized by ferric iron
had little eﬀect on the rate of oxidation (Figure 2E).
Eﬀects of Iron Chelators. To assess the dependency of the
various phases of the oxidation process on the presence of iron,
the iron chelators diethylenetriaminepentaacetic acid (DTPA)
and desferrioxamine were added during the diﬀerent phases and
the eﬀect on the attenuance was observed. DTPA (10 μM),
added to LDL at the start of the incubation or during the rapid
phase, caused almost complete inhibition of the oxidation
(Figure 3A). Addition of DTPA during the slow phase of
oxidation caused the rate of oxidation to decrease, but the LDL
was still able to aggregate and later sediment. Adding DTPA
during the aggregation phase did not greatly aﬀect the
aggregation or sedimentation. These data suggest that iron
catalyzes oxidation of LDL during the lag, rapid, and slow
phases and that when LDL is oxidized suﬃciently it is able to
aggregate in the absence of iron, which is consistent with the
results shown in Figure 1C.
Unlike DTPA, addition of desferrioxamine (100 μM) at the
start of the incubation or during the rapid phase partially
inhibited the oxidation but did not fully inhibit it (Figure 3B).
Addition of desferrioxamine at the start of the slow phase of
oxidation caused the rate of the reaction to decrease, but the
LDL was able to aggregate and then sediment. Interestingly,
adding desferrioxamine at the start of the aggregation phase
actually caused a faster increase in attenuance (p < 0.05; n = 3
independent experiments). These data agree with the DTPA
data in that the lag, slow, and rapid oxidation phases are
dependent on iron. It appears that desferrioxamine is less able
than DTPA to inhibit LDL oxidation and may actually promote
LDL modiﬁcation when LDL is suﬃciently oxidized.
Eﬀect of α-Tocopherol Enrichment on the Oxidation
of LDL by Iron. α-Tocopherol can inhibit18,21 or sometimes
promote22 LDL oxidation. We therefore investigated its eﬀect
on the oxidation of LDL by iron at pH 4.5. LDL was enriched
with α-tocopherol via addition of α-tocopherol to plasma and
isolation of the LDL.18 The α-tocopherol content was increased
∼4.5 times from 6.5 ± 4.4 to 29.5 ± 9.1 nmol/mg of protein (p
< 0.005; n = 6 independent experiments). As expected, α-
tocopherol enrichment increased the length of the lag phase of
oxidation of LDL by 5 μM CuSO4 at pH 7.4 (Figure 4). The
Figure 3. Eﬀect of the iron chelators DTPA and desferrioxamine (both
obtained from Sigma-Aldrich) on oxidation of LDL by FeSO4 at pH
4.5. LDL (50 μg of protein/mL) in NaCl/sodium acetate buﬀer (pH
4.5) was incubated with 5 μM FeSO4 at 37 °C in quartz cuvettes.
DTPA (A, ﬁnal concentration of 10 μM) or desferrioxamine (B, ﬁnal
concentration of 100 μM) was added to the cuvettes at the start of the
incubation (arrow 1), during the rapid oxidation phase (arrow 2),
during the slow oxidation phase (arrow 3), or during the aggregation
phase (arrow 4). Oxidation and UV scattering were monitored by
measuring the change in attenuance at 234 nm against appropriate
reference cuvettes. These data are representative examples of four
independent experiments.
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time taken to increase the attenuance at 234 nm by 0.1
increased from 37 ± 9 to 153 ± 28 min (p < 0.05; n = 4
independent experiments). Very diﬀerent results were obtained
when 5 μM FeSO4 at pH 4.5 was used. The oxidation of α-
tocopherol-enriched LDL started immediately with no lag
period and was initially faster than that of nonenriched LDL,
which had a lag period followed by a rapid phase of oxidation
(Figure 4). The oxidation of the nonenriched LDL overtook
the oxidation of the α-tocopherol-enriched LDL later in the
experiment.
Chemical Characteristics of LDL Oxidized by Iron at
pH 4.5. Establishing the lipid composition of LDL oxidized by
iron at lysosomal pH might help us to assess the atherogenicity
of the oxidized LDL formed in this manner. LDL (2 mg of
protein/mL) was oxidized in the presence of FeSO4 (50 μM) at
37 °C in NaCl/sodium acetate buﬀer (concentrations of LDL
and FeSO4 were higher than those used for spectrophotometry
because of sensitivity issues). There was a trend for the
nonesteriﬁed cholesterol levels measured by HPLC to decline
during the oxidation, but this was not statistically signiﬁcant
(Figure 5A). The levels of the major polyunsaturated
cholesteryl esters in LDL, cholesteryl linoleate (CL) and
cholesteryl arachidonate (CA), declined greatly during
oxidation by iron (Figure 5C,D). As expected, the levels of
CA declined somewhat more rapidly than those of CL, which is
probably due to the increased number of double bonds making
it more susceptible to free radical attack.23
The level of the cholesterol oxidation product, 7-
ketocholesterol, increased greatly after a long lag period from
0.24 ± 0.14 to 101 ± 21 nmol/mg of LDL protein after
oxidation for 48 h (Figure 5B). Cholesteryl linoleate hydro-
peroxide (CLOOH) levels increased to 457 ± 86 nmol/mg of
LDL protein after oxidation for 24 h and then appeared to
decrease during the next 24 h (Figure 5E). Total hydroperoxide
levels, as determined using a triiodide assay, peaked at 697 ± 91
nmol/mg of LDL protein after oxidation for 24 h (Figure 5F).
Hence, at the peak level of hydroperoxides, cholesteryl linoleate
hydroperoxide accounted for most of the hydroperoxides.
Other cholesteryl ester hydroperoxides and phospholipid,
triacylglycerol, and protein hydroperoxides have not been
measured here and may account for the remainder of the total
hydroperoxides. Interestingly, in contrast to apparent CLOOH
levels, total hydroperoxide levels did not decline much between
24 and 48 h.
The level of TBARS, which consist mainly of malondialde-
hyde,23 increased to 23.9 ± 2.9 nmol/mg of LDL protein at 24
h and subsequently decreased at 48 h (Figure 5G).
The electronegativity of the oxidized LDL was also assessed
as a measure of the extent of LDL protein oxidation (Figure
5H). The REM of the LDL, measured in agarose gels at pH 8.6,
increased slightly as the duration of oxidation increased,
reaching 1.3 ± 0.07 after 6 h. LDL oxidized for ≥12 h could
not be loaded onto the gel eﬀectively because the LDL was
highly aggregated.
■ DISCUSSION
Lysosomal iron is a candidate for catalyzing the oxidation of
LDL in vivo. Redox-active iron has been shown to be present in
lysosomes,24 probably because of the degradation of ferritin, the
turnover of iron-containing organelles or the phagocytosis of
erythrocytes. Most of the labile iron in cells is present in
lysosomes,25 and the concentration of chelatable iron in some
endosomes/lysosomes is ∼16 μM.26 The concentration of
redox-active iron in lysosomes is therefore probably above 5
μM. We have used a concentration of FeSO4 of 5 μM for the
spectrophotometry studies and 50 μM for the HPLC studies
(as the LDL concentration needed to be much higher for the
HPLC studies, because of sensitivity issues, and we therefore
needed to increase the FeSO4 concentration, as well). These
concentrations of FeSO4 might be broadly consistent with the
concentrations of redox-active iron in lysosomes (although the
nature of the redox-active iron and its ligands in lysosomes are
unclear).
In agreement with work conducted previously in this
laboratory,6 LDL was oxidized eﬀectively by 5 μM FeSO4 at
lysosomal pH (pH 4.5) but was not oxidized eﬀectively at the
pH of plasma or normal interstitial ﬂuid (pH 7.4) (Figure 1A).
In contrast, CuSO4 oxidized LDL eﬀectively at pH 7.4, but not
so well at pH 4.5.16 Acidity increases the solubility of iron and
should allow it to oxidize LDL more eﬀectively. Extracellular
ﬂuids have a high antioxidant capacity, with the oxidation of
LDL by transition metals being inhibited greatly by just a few
percent of serum or interstitial ﬂuid.8 Oxidation of LDL by iron
within lysosomes might help to explain why LDL can be
oxidized in atherosclerotic lesions in the presence of strong
antioxidant protection in the interstitial ﬂuid of the arterial
intima.
The lipid composition of LDL oxidized by iron at lysosomal
pH over time has been characterized (Figure 5). The levels of
cholesteryl linoleate and arachidonate decreased greatly, mainly
because of the oxidation of their polyunsaturated fatty acid
(PUFA) moieties.27 PUFA are oxidized via a free radical chain
reaction, which is initiated by the abstraction of a hydrogen
atom by a free radical at a bisallylic methylene group. As
expected, cholesteryl arachidonate was oxidized somewhat
more rapidly than cholesteryl linoleate, because of its increased
number of double bonds. The levels of the cholesteryl linoleate
oxidation product, cholesteryl linoleate hydroperoxide
(CLOOH), increased signiﬁcantly for periods of oxidation of
Figure 4. Comparison of the oxidation of α-tocopherol-enriched LDL
by FeSO4 at pH 4.5 and CuSO4 at pH 7.4. Control LDL (50 μg of
protein/mL) was incubated with NaCl/sodium acetate buﬀer (pH 4.5)
containing 5 μM FeSO4 (thick solid line) or NaCl/MOPS buﬀer (pH
7.4) containing 5 μM CuSO4 (thin solid line) at 37 °C in quartz
cuvettes. LDL enriched with α-tocopherol was incubated in the same
experiment with NaCl/sodium acetate buﬀer (pH 4.5) containing 5
μM FeSO4 (···) or NaCl/MOPS buﬀer (pH 7.4) containing 5 μM
CuSO4 (---). Oxidation was monitored by measuring the change in
attenuance at 234 nm against appropriate reference cuvettes. These
data are representative examples of at least three independent
experiments.
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≤24 h and then appeared to decrease again. The total level of
hydroperoxides was measured using a triiodide assay and also
increased up to 24 h. It then decreased only slowly over the
next 24 h. During LDL oxidation, lipid hydroperoxides may
decompose to form aldehydes, such as malondialdehyde28 and
epoxy lipids.29 This decomposition probably accounted for the
slow decrease in the total level of hydroperoxides after
oxidation for 24 h. The levels of CLOOH may have declined
faster after 24 h than the levels of total hydroperoxides because
CLOOH might have become oxidized also on its cholesterol
Figure 5. Chemical characteristics of LDL oxidized by FeSO4 at pH 4.5. LDL (2 mg of protein/mL) was oxidized with FeSO4 (50 μM) at 37 °C in
buﬀer at pH 4.5. At various time points up to 48 h, LDL oxidation was stopped by addition of EDTA (4 mM) and BHT (80 μM). LDL was assayed
by reverse-phase HPLC for nonesteriﬁed cholesterol [Chol (A)], 7-ketocholesterol [7KC (B)], cholesteryl linoleate [CL (C)], cholesteryl
arachidonate [CA (D)], and cholesteryl linoleate hydroperoxide [CLOOH (E)]. LDL was assayed for total hydroperoxides by a triiodide assay
[ROOH (F)], for thiobarbituric acid-reactive substances [TBARS (G)], and for relative electrophoretic mobility [REM (H); note the diﬀerent time
scale]. Graphs represent the mean ± the SEM of at least three independent experiments. Diﬀerences between values at each time point and the zero
time point were determined by ANOVA and a Dunnett’s post-hoc test. *p < 0.05.
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moiety, causing its HPLC retention time to change, although it
may have retained the hydroperoxide group on its fatty acyl
moiety and been detected in the triiodide assay.
When LDL is oxidized with copper at 37 °C and pH 7.4,
lipid hydroperoxides are formed during the propagation phase
of oxidation and then decompose fairly rapidly.11,14 In contrast,
when LDL is oxidized by iron at 37 °C at acidic pH, the net
hydroperoxide levels fall only slowly between 24 and 48 h
(Figure 5F), in agreement with our previous work.30 The lipid
composition of LDL oxidized by iron at pH 4.5 and 37 °C for
12 h (Figure 5) was similar to that of LDL oxidized by copper
at pH 7.4 and 4 °C for 12 h,14 i.e., rich in hydroperoxides but
low in oxysterols. The high levels of lipid hydroperoxides
present in LDL oxidized by iron at lysosomal pH may confer
atherogenic properties to the LDL, which diﬀer from those of
copper-oxidized LDL. Kritharides et al.31 showed that treat-
ment of murine peritoneal macrophages with acetylated or
aggregated LDL, subjected to mild oxidation, led to a lysosomal
or prelysosomal accumulation of CLOOH and CLOH, which
impaired the breakdown of cholesteryl esters. The accumu-
lation of lipid hydroperoxides within the lysosome might
therefore compromise lysosomal function. Furthermore, data
presented here show that oxidized LDL aggregates sponta-
neously and rapidly at lysosomal pH (Figure 1C). This may
weaken the ability of lysosomal enzymes to degrade it
eﬀectively. Atherosclerosis has previously been described as
having features of a lysosomal storage disorder, whereby
engorgement of lysosomes with lipids impairs their function,32
and our data lend further support to this concept.
A wide variety of aldehydes are formed from the
decomposition of lipid hydroperoxides. A major aldehyde
formed is malondialdehyde.28 The levels of TBARS (mainly
malondialdehyde) increased after oxidation for ≤24 h by iron at
pH 4.5 and then decreased (Figure 5G). The decrease might be
explained by the further reaction of malondialdehyde with
amino groups of the lysyl residues of apolipoprotein B-100,
which would abolish the positive charge of these residues.23
The level of the cholesterol oxidation product 7-ketocholes-
terol remained very low for some time but then increased
greatly (Figure 5B). The level of 7-ketocholesterol was also
increased in macrophages when they oxidized LDL in their
lysosomes,6 and 7-ketocholesterol is present in much larger
amounts in human atherosclerotic lesions than in normal
arteries.33
A slight increase in REM at pH 8.6 was detected after
oxidation for ≤6 h (Figure 5H). LDL oxidized for ≥12 h could
not be loaded onto an agarose gel, because of its high level of
aggregation, but it is possible that the net negative charge of
LDL continued to increase. The isoelectric point of native LDL
has been reported to be 5.1−5.8,34,35 so at pH 5.1−5.8, LDL
will have no net charge. At pH 7.4 or 8.6 (the pH at which
electrophoresis was conducted), LDL would have a net
negative charge, but at the pH of lysosomes, ∼4.5, it would
have a net positive charge. The LDL particles would therefore
repel each other; however, as oxidation proceeds and the net
positive charge becomes smaller (Figure 5H), the repulsion
would weaken, and this may favor the aggregation of the LDL
particles.
Oxidation of LDL by ferrous iron at lysosomal pH proceeds
with lag, rapid oxidation, slow oxidation, aggregation, and
sedimentation phases (Figure 1A), in agreement with our
earlier ﬁndings.6 The pattern of oxidation with ferric iron was
similar to that with ferrous iron; however, there was a decrease
in the rates of the rapid and slow phases of oxidation and
aggregation (Figure 2A). Kuzuya et al.36 found that ferrous iron
oxidized LDL faster than did ferric iron in an unbuﬀered NaCl
solution initially at pH 7.4. There is evidence that lysosomes
contain cysteine and therefore have a reducing environment37
(but this is controversial38), and this would favor the ferrous
oxidation state of iron. In fact, the phagolysosomes of
macrophages are known to contain ferrous (and probably
ferric) iron.20
Iron may be able to initiate the oxidation of LDL by reacting
with preexisting lipid hydroperoxides in the LDL particle.23
+ → + ++ + • −Fe LOOH Fe LO OH (fast)2 3 (1)
+ → + ++ + • +Fe LOOH Fe LOO H (slow)3 2 (2)
Fe2+ is believed to react faster with lipid hydroperoxides
(reaction 1) than does Fe3+ (reaction 2), as the rate constant
for the analogous reaction of Fe2+ with H2O2 is 68 M
−1 s−1
whereas that for Fe3+ with H2O2 is ∼4 × 10−6 M−1 s−1.
39 This
may explain why the oxidation of LDL is slower with Fe3+.
Interestingly, adding higher concentrations of Fe2+ shortened
the lag phase and increased the rates of the rapid, slow, and
aggregation phases (Figure 2B), but adding a higher
concentration of Fe3+ had little eﬀect (Figure 2C). This
suggests that it is the concentration of Fe2+, rather than Fe3+,
that determines the rate-limiting step in the oxidation of LDL.
The results shown in panels D and E of Figure 2 are consistent
with this suggestion. Adding extra Fe2+ at various times when
the oxidation was already underway caused an immediate rapid
burst of oxidation, whereas adding extra Fe3+ had little eﬀect.
These results suggest that the rapid phase of oxidation is
mediated by the reaction of Fe2+ with LDL and the slow phase
occurs when the levels of Fe3+ predominate.
DTPA is a metal ion chelator with a high aﬃnity for iron and
is able to bind both ferrous and ferric iron.40 Adding this
chelator at the start of the oxidation or during the rapid
oxidation phase caused great inhibition of LDL oxidation with
iron at pH 4.5 (Figure 3A). When DTPA was added during the
slower oxidation phase, the rate of change of attenuance was
decreased substantially, but the LDL was still able to aggregate,
as indicated by the aggregation and sedimentation phases.
These data suggest that the rapid and slower oxidation phases
of LDL modiﬁcation are iron-dependent and that LDL is able
to aggregate only after it has been oxidized to a certain extent,
corresponding to the slow oxidation phase. The aggregation
phase can proceed in the absence of iron.
Adding another iron chelator, desferrioxamine, at the start of
LDL oxidation or during the rapid or slow phases of oxidation
caused a partial inhibition of LDL oxidation but was less
eﬀective than adding DTPA (Figure 3B). Desferrioxamine
binds Fe2+ within seconds or less above pH 7.0 but requires
many minutes at pH 4.5.41 Surprisingly, when desferrioxamine
was added at the beginning of the aggregation phase of LDL
modiﬁcation, the rate of the modiﬁcation was actually
increased. Pro-oxidant eﬀects of desferrioxamine have been
reported.42 It might be argued that desferrioxamine was acting
by pulling the equilibrium in eq 1 over to the right, as it binds
Fe3+ with a higher aﬃnity than Fe2+,41 and accelerating the
breakdown of LOOH. Arguing against this is the fact that there
is a rapid burst of LDL oxidation when Fe 2+ is added to
partially oxidized LDL in the absence of an added iron chelator
(Figure 2D). The reason for the diﬀerent behaviors of
desferrioxamine and DTPA is unknown but may be related
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to their diﬀerent stability constants for Fe2+ and Fe3+, their
diﬀerent standard reduction potentials,40 or the electron
donating ability of desferrioxamine,43 which might reduce
Fe3+ to Fe2+ and promote reaction 1.
Desferrioxamine injections inhibited atherosclerosis in
cholesterol-fed rabbits.44 Desferrioxamine inhibits intralysoso-
mal iron redox chemistry45 and inhibits the lysosomal oxidation
of LDL in macrophages.6 Targetting iron chelators to
lysosomes might be a potential strategy for slowing the
lysosomal oxidation of LDL, if toxicity issues could be
overcome.
α-Tocopherol enrichment of LDL had complex eﬀects on the
oxidation of LDL by iron at pH 4.5, whereas its antioxidant
eﬀects on oxidation of LDL by copper at pH 7.4 were as
expected (Figure 4). There was initially a pro-oxidant eﬀect of
α-tocopherol enrichment on the oxidation of LDL by iron,
followed by an antioxidant eﬀect. The initial pro-oxidant eﬀect
might possibly be explained by tocopherol-mediated perox-
idation, in which an α-tocopheroxyl radical abstracts a hydrogen
atom from a polyunsaturated fatty acyl group.22 There may
later have been a net antioxidant eﬀect of α-tocopherol
enrichment. Large clinical trials have shown that α-tocopherol
supplementation does not usually decrease the risk of
cardiovascular disease.46,47 The absence of an initial antioxidant
eﬀect of α-tocopherol enrichment on oxidation of LDL by iron
at lysosomal pH might possibly be relevant to this lack of
protection.
These data lend support to the ﬁnding that LDL can be
oxidized within lysosomes. High levels of lipid hydroperoxides
and 7-ketocholesterol can be formed in LDL by iron at
lysosomal pH, and the LDL becomes highly aggregated and
may therefore be diﬃcult to degrade with lysosomal hydrolases.
This suggests that lysosomal oxidation of LDL might lead to
lysosomal lipid engorgement and lysosomal dysfunction in
atherosclerosis.
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